back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-11-20 11:22 Tx date 2022-11-10 |
$SKYE
Skye Bioscience, Inc. |
Emerald Health Sciences Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Convertible Debt
00 - Opening Balance-Initial SEDI Report
|
$2,280,470 | ||
| Filed 2022-11-19 16:36 Tx date 2022-11-10 |
$SKYE
Skye Bioscience, Inc. |
Emerald Health Sciences Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
16,641,486 | ||
| Filed 2022-11-19 16:28 Tx date 2022-11-10 |
$SKYE
Skye Bioscience, Inc. |
Emerald Health Sciences Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
111,387,251 | ||
| Filed 2022-11-18 11:24 Tx date 2022-11-10 |
$SKYE
Skye Bioscience, Inc. |
Arsenault, Kaitlyn
5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSU
00 - Opening Balance-Initial SEDI Report
|
1,000,000 | ||
| Filed 2022-11-18 11:24 Tx date 2022-11-10 |
$SKYE
Skye Bioscience, Inc. |
Arsenault, Kaitlyn
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
3,770,000 | ||
| Filed 2022-11-18 11:21 Tx date 2022-11-10 |
$SKYE
Skye Bioscience, Inc. |
Ward, Keith
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
250,000 | ||
| Filed 2022-11-18 11:20 Tx date 2022-11-10 |
$SKYE
Skye Bioscience, Inc. |
Dalesandro, Margaret
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
400,000 | ||
| Filed 2022-11-18 11:18 Tx date 2022-11-10 |
$SKYE
Skye Bioscience, Inc. |
Tyle, Praveen
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
275,000 | ||
| Filed 2022-11-18 11:15 Tx date 2022-11-10 |
$SKYE
Skye Bioscience, Inc. |
Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
877,500 | ||
| Filed 2022-11-18 11:11 Tx date 2022-11-10 |
$SKYE
Skye Bioscience, Inc. |
Dhillon, Punit
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSU
00 - Opening Balance-Initial SEDI Report
|
2,000,000 | ||
| Filed 2022-11-18 11:10 Tx date 2022-11-10 |
$SKYE
Skye Bioscience, Inc. |
Dhillon, Punit
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
331,500 | ||
| Filed 2022-11-18 11:10 Tx date 2022-11-10 |
$SKYE
Skye Bioscience, Inc. |
Dhillon, Punit
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
13,850,000 | ||
| Filed 2022-11-18 11:09 Tx date 2022-11-10 |
$SKYE
Skye Bioscience, Inc. |
Dhillon, Punit
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+3,742,264 vol |
4,742,264 | |
| Filed 2022-11-18 11:07 Tx date 2022-11-10 |
$SKYE
Skye Bioscience, Inc. |
Dhillon, Punit
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,000,000 |